Mondaq UK: Food, Drugs, Healthcare, Life Sciences
Elkington and Fife LLP
Following a Notice of the European Commission related to certain parts of the EU Biotech Directive (98/44/EC), the EPO has decided to stay all examination and opposition proceedings...
Mayer Brown
The eligibility is based on the risk of EU residents becoming affected by the disease.
Clyde & Co
A GP defended at trial by Richard Manstoff of the Clyde's Healthcare team was this month found not to have breached any duty of care owed to a patient who presented with a swelling ...
Deloitte
There is increasing evidence that a wholesale transformation of health and social care delivery is urgently needed.
Deloitte
This week our colleague Sriram Prakash, Deloitte's global lead for mergers and acquisitions (M&A) insight, published the cross industry M&A Index Outlook for 2017.
Arnold & Porter Kaye Scholer LLP
2017 has started with a bang on the data protection front. There have been several developments these past few months, ranging from updates on the new EU General Data Protection Regulation ("GDPR"), coming into force in May 2018, to the establishment of a Swiss-EU Privacy Shield.
Deloitte
Most healthcare systems are battling with the challenge of delivering both better patient outcomes – in an environment of increasing prevalence of diseases – while managing escalating costs.
MacRoberts
The recent Avian Flu outbreak across Europe has been raising cholesterol across the industry since December of last year when the government issued a prevention order requiring farmers to keep their birds inside to help prevent the spread of the disease.
Arnold & Porter Kaye Scholer LLP
The National Institute for health and Care Excellence (NICE) provides guidance to the NHS in England on the clinical and cost effectiveness of selected new and established technologies through its healthcare technology assessment (HTA) program.
Clyde & Co
The Department of Health has recently launched a consultation into fixed recoverable costs in clinical negligence claims.
Deloitte
This highlights the key challenges, trends and opportunities facing the global life science industry in 2017 and beyond and what is currently being done or could be done to respond to these challenges.
Jones Day
Two companies have applied to the Food Standards Agency ("FSA") for approval to market their novel food products in the EU under the Novel Food Regulation (EC) 258/97.
Clyde & Co
A 'Never Event' is a term used by the NHS to describe serious patient safety incidents which are largely or wholly preventable.
Deloitte
Many health plans are raising the bar for value as they try to rein in drug spending.
Deloitte
After studying bioengineering and completing a PhD in the San Francisco Bay Area and a two-year postdoctoral research fellowship in London, Mark has spent the past four years analysing global health policy.
Deloitte
Our recent report Vital Signs: how to deliver better healthcare across Europe highlighted, as one of our vital signs, patient engagement and empowerment.
Deloitte
This week's blog is from Rachel Alsop, one of our colleagues in our strategy consulting team who spends some of her own time volunteering with the humanitarian mapping charity, MapAction.
Taylor Wessing
Paul England discusses what recent events tell us about the intended role of the life sciences sector in the post-Brexit economy.
Clyde & Co
The NHS Litigation Authority has recently launched a programme of reform for its main indemnity scheme, the Clinical Negligence Scheme for Trusts (CNST).
Deloitte
In January, Deloitte published its 2017 Global healthcare sector outlook, which confirms that the challenges of providing and funding health care around the globe have remained fairly persistent...
Latest Video
Most Popular Recent Articles
Elkington and Fife LLP
Following a Notice of the European Commission related to certain parts of the EU Biotech Directive (98/44/EC), the EPO has decided to stay all examination and opposition proceedings...
Deloitte
This highlights the key challenges, trends and opportunities facing the global life science industry in 2017 and beyond and what is currently being done or could be done to respond to these challenges.
Deloitte
Most healthcare systems are battling with the challenge of delivering both better patient outcomes – in an environment of increasing prevalence of diseases – while managing escalating costs.
Deloitte
This week our colleague Sriram Prakash, Deloitte's global lead for mergers and acquisitions (M&A) insight, published the cross industry M&A Index Outlook for 2017.
Arnold & Porter Kaye Scholer LLP
2017 has started with a bang on the data protection front. There have been several developments these past few months, ranging from updates on the new EU General Data Protection Regulation ("GDPR"), coming into force in May 2018, to the establishment of a Swiss-EU Privacy Shield.
Taylor Wessing
1.The trade mark shall not entitle the proprietor to prohibit its use in relation to goods which have been put on the market in the Community under that trade mark by the proprietor or with his consent.
Clyde & Co
The Department of Health has recently launched a consultation into fixed recoverable costs in clinical negligence claims.
Latham & Watkins
The CAT in the UK heard on 17 January 2017 an application by Flynn Pharma Ltd and Flynn Pharma (Holdings) Ltd to suspend the Competition and Markets Authority's direction to reduce the price of an epilepsy drug.
Arnold & Porter Kaye Scholer LLP
The National Institute for health and Care Excellence (NICE) provides guidance to the NHS in England on the clinical and cost effectiveness of selected new and established technologies through its healthcare technology assessment (HTA) program.
Allen & Overy
Cybersecurity continues to be headline-grabbing news, particularly following recent reports of high-profile cyber attacks on a number of major well-known corporations.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with